Fig. 2From: The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: a meta‑analysisRisk of bias assessment. A risk of bias graph for all the included RCTs. The items are scored ( +) low risk; (-) high risk; (?) unclear risk of bias. B risk of bias summaryBack to article page